Weight loss in morbidly obese patients leads to significant decreases in C-reactive protein (CRP) and interleukin-6 (IL-6) concentrations

Administration of the oral antidiabetic drug (OAD) repaglinide (called Prandin® in the United States, NovoNorm® in Europe, and Gluconorm® in Canada) in people with type 2 diabetes resulted in significantly greater reductions in blood glucose markers than nateglinide when taken in combination with metformin.

New study results show a direct relationship between the diabetes knowledge of the patient and their A1c results.

Attenuated heart rate recovery (HRR) following maximal exercise test is a predictor of mortality in healthy adults and in those referred for diagnostic testing

Increased homocysteine concentrations are associated with an increased risk for incidence of nephropathy and proliferative retinopathy.

Choosing healthy, low-fat foods is just as effective for type 2 diabetes patients to control glucose levels as more complex meal plans that emphasize weight loss, Emory researchers said.

Population-based lower extremity screening combined with a treatment program leads to a progressive decrease in the rate of amputation in patients with diabetes

Decline in renal functioning begins soon after the onset of microalbuminuria in patients with type 1 diabetes, which is contrary to widespread the belief that decline in renal function decline results from longstanding exposure to proteinuria.

Cholesterol not as important as thought, coronary-artery calcification, is a much better tool to gauge a person’s heart health.

There is a new prototype treatment technology on the horizon, designed by Binghamton University chemistry professor C.J. Zhong. His “pumpless pump” could make insulin delivery and blood-sugar monitoring as easy as child’s play for the 13,000 children diagnosed each year with Type 1 diabetes.